Parker Institute for Cancer Immunotherapy shared a post on LinkedIn:
“A year after NIH funding cuts, 27% of researchers report their funding hasn’t been restored. This is not just about budgets; it is about the future of science, and as Cassie McGrath highlights in Healthcare Brew, the real-world impact is already being felt.
As PICI CEO Karen Knudsen shared with Healthcare Brew, these funding cuts have a large impact on researchers and patients, and stall bold innovative science. PICI is working to keep progress moving by backing high-risk, high-reward science and accelerating collaboration to turn all cancers into curable diseases.
Other articles from Parker Institute for Cancer Immunotherapy.